Thubrikar Aortic Valve partners with MAC’s MEDICAL Group and expands the TAVI-1 CE Mark trial of the Optimum TAVI SystemTM

COLLEGEVILLE, Pa.--(BUSINESS WIRE)-- #TAVI--Thubrikar Aortic Valve, Inc. today announced its partnership with MAC’s MEDICAL Group, a distributor of cardiovascular devices in Europe, and MAC’s CEO, Ante Cicin-Sain. As part of the exclusive distribution rights agreement for Europe, Mr. Cicin-Sain, MAC’s MEDICAL Group, and their affiliates will co-participate in financing up to 50 implants toward the CE Mark approval of the Optimum TAVI SystemTM. They will also have the option to invest an addition